Pharmaceutical manufacturer Antibiotice Iasi targets a 22% increase in its turnover to 200 million RON (63.4 million euros) and intends to achieve a 3.5% share of the domestic drug market, 0.3% more than in 2005. The company estimates a gross profit worth 29.5 million RON (8.5 million euros), a 24.4% increase against the figure seen in 2005.
“The development strategy for this year mainly targets the expansion of the volume of exports, by registering and selling new products on the international market and by conducting significant investments meant to increase competitiveness of the company”s products, with a long and medium term effect on the turnover,” a company release reads. Investments for this
year are directed towards modernising the injectable products department, particularly regarding the production of injectable cephalosporins and inaugurating a wastewater filtering station and a waste incinerator. ZF